Cargando…

Genomic similarity between gastroesophageal junction and esophageal Barrett's adenocarcinomas

The current high mortality rate of esophageal adenocarcinoma (EAC) reflects frequent presentation at an advanced stage. Recent efforts utilizing fluorescent peptides have identified overexpressed cell surface targets for endoscopic detection of early stage Barrett's-derived EAC. Unfortunately,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ferrer-Torres, Daysha, Nancarrow, Derek J., Kuick, Rork, Thomas, Dafydd G., Nadal, Ernest, Lin, Jules, Chang, Andrew C., Reddy, Rishindra M., Orringer, Mark B., Taylor, Jeremy M. G., Wang, Thomas D., Beer, David G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342387/ https://www.ncbi.nlm.nih.gov/pubmed/27363029 http://dx.doi.org/10.18632/oncotarget.10253

Ejemplares similares

IGFBP2 modulates the chemoresistant phenotype in esophageal adenocarcinoma
por: Myers, Amy L., et al.
Publicado: (2015)

Osteopontin (OPN/SPP1) isoforms collectively enhance tumor cell invasion and dissemination in esophageal adenocarcinoma
por: Lin, Jules, et al.
Publicado: (2015)

Immune determinants of Barrett’s progression to esophageal adenocarcinoma
por: Lagisetty, Kiran H., et al.
Publicado: (2021)

Identification and validation of FGFR2 peptide for detection of early Barrett's neoplasia
por: Zhou, Juan, et al.
Publicado: (2017)

Similarity of aberrant DNA methylation in Barrett's esophagus and esophageal adenocarcinoma
por: Smith, Eric, et al.
Publicado: (2008)

Differential expression of Hsp27 in normal oesophagus, Barrett's metaplasia and oesophageal adenocarcinomas
por: Soldes, O S, et al.
Publicado: (1999)

UBCH5 Family Members Differentially Impact Stabilization of Mutant p53 via RNF128 Iso1 During Barrett’s Progression to Esophageal Adenocarcinoma
por: Ray, Paramita, et al.
Publicado: (2021)

Chronic gastroesophageal reflux disease shares genetic background with esophageal adenocarcinoma and Barrett's esophagus
por: Gharahkhani, Puya, et al.
Publicado: (2016)

Correlation of the location of superficial Barrett’s esophageal adenocarcinoma (s-BEA) with the direction of gastroesophageal reflux
por: Omae, Masami, et al.
Publicado: (2016)

Gastroesophageal reflux disease, Barrett esophagus, and esophageal adenocarcinoma – where do we stand?
por: Mikolašević, Ivana, et al.
Publicado: (2018)

Gastroesophageal Reflux in Relation to Adenocarcinomas of the Esophagus: A Pooled Analysis from the Barrett’s and Esophageal Adenocarcinoma Consortium (BEACON)
por: Cook, Michael B., et al.
Publicado: (2014)

The Frequencies of Gastroesophageal and Extragastroesophageal Symptoms in Patients with Mild Erosive Esophagitis, Severe Erosive Esophagitis, and Barrett's Esophagus in Taiwan
por: Kao, Sung-Shuo, et al.
Publicado: (2013)

Paired Exome Analysis of Barrett’s Esophagus and Adenocarcinoma
por: Stachler, Matthew D., et al.
Publicado: (2015)

Recurrent intestinal metaplasia at the gastroesophageal junction following endoscopic eradication of dysplastic Barrett’s esophagus may not be benign
por: Cameron, Georgina R., et al.
Publicado: (2016)

MAP3K3 expression in tumor cells and tumor-infiltrating lymphocytes is correlated with favorable patient survival in lung cancer
por: He, Yanli, et al.
Publicado: (2015)

A Novel Serum 4-microRNA Signature for Lung Cancer Detection
por: Nadal, Ernest, et al.
Publicado: (2015)

Evolving Management Strategies for Metastatic Esophageal and Gastroesophageal Junction Adenocarcinoma
por: Das, Satya, et al.
Publicado: (2018)

Understanding the Challenges Faced by Esophageal and Gastroesophageal Junction Cancer Survivors
por: McGillivray, Erin, et al.
Publicado: (2023)

The Impact of Signet Ring Cell Differentiation on Outcome in Patients with Esophageal and Gastroesophageal Junction Adenocarcinoma
por: van Hootegem, Sander J. M., et al.
Publicado: (2019)

E-cadherin expression in primary and metastatic thoracic neoplasms and in Barrett's oesophagus.
por: Bongiorno, P. F., et al.
Publicado: (1995)

Real-world upper endoscopy utilization patterns among patients with gastroesophageal reflux disease, Barrett esophagus, and Barrett esophagus-related esophageal neoplasia in the United States
por: Sharma, Prateek, et al.
Publicado: (2023)

Wide-field ESD for Barrett's adenocarcinoma at the gastroesophageal junction: technical approaches to facilitate en bloc R0 resection
por: Emura, Fabian, et al.
Publicado: (2022)

Impact of Radiation Dose on Postoperative Complications in Esophageal and Gastroesophageal Junction Cancers
por: Kastelowitz, Noah, et al.
Publicado: (2021)

Biomarkers in the molecular pathogenesis of esophageal (Barrett) adenocarcinoma
por: Williams, L.J., et al.
Publicado: (2006)

Trends in surgical techniques for the treatment of esophageal and gastroesophageal junction cancer: the 2022 update
por: de Groot, E M, et al.
Publicado: (2023)

Characterizing isoform switching events in esophageal adenocarcinoma
por: Zhang, Yun, et al.
Publicado: (2022)

Preoperative Chemoradiotherapy Versus Perioperative Chemotherapy for Patients With Resectable Esophageal or Gastroesophageal Junction Adenocarcinoma
por: Anderegg, M. C. J., et al.
Publicado: (2017)

Neoadjuvant Treatment Strategies for Resectable Proximal Gastric, Gastroesophageal Junction and Distal Esophageal Cancer
por: Ahmad, M. Usman, et al.
Publicado: (2022)

Pembrolizumab for first-line treatment of advanced unresectable or metastatic esophageal or gastroesophageal junction cancer
por: Hirose, Toshiharu, et al.
Publicado: (2023)

Anastomotic Leaks following Esophagectomy for Esophageal and Gastroesophageal Junction Cancer: The Key Is the Multidisciplinary Management
por: Ortigão, Raquel, et al.
Publicado: (2021)

Two decades of gastric and gastroesophageal junction cancer surgery
por: Plum, Patrick S., et al.
Publicado: (2023)

Individual Participant Data Network Meta-Analysis of Neoadjuvant Chemotherapy or Chemoradiotherapy in Esophageal or Gastroesophageal Junction Carcinoma
por: Faron, Matthieu, et al.
Publicado: (2023)

Mucosa-Associated Microbiota in Barrett's Esophagus, Dysplasia, and Esophageal Adenocarcinoma Differ Similarly Compared With Healthy Controls
por: Peter, Shajan, et al.
Publicado: (2020)

Relevance of Position and Movement of the Gastroesophageal Junction in Gastroesophageal Reflux Disease
por: Lee, Yeong Yeh
Publicado: (2013)

Alteration of the esophageal microbiota in Barrett's esophagus and esophageal adenocarcinoma
por: Lv, Jing, et al.
Publicado: (2019)

Chemoprevention in Barrett’s esophagus and esophageal adenocarcinoma
por: Alkhayyat, Motasem, et al.
Publicado: (2021)

Recurring Translocations in Barrett’s Esophageal Adenocarcinoma
por: Bajpai, Manisha, et al.
Publicado: (2021)

Helicobacter pylori infection and gastroesophageal reflux disease - Barrett’s esophagus sequence “dilemma”
por: Kountouras, Jannis, et al.
Publicado: (2015)

(18)F-FDG PET intensity correlates with a hypoxic gene signature and other oncogenic abnormalities in operable non-small cell lung cancer
por: Heiden, Brendan T., et al.
Publicado: (2018)

Conditional survival in patients with esophageal or gastroesophageal junction cancer after receiving various treatment modalities
por: Deng, Wei, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ri2776hgc1d7a10sbrkb8vatl5